GRTS - Gritstone Bio Inc
IEX Last Trade
0.4766
0.024 5.120%
Share volume: 744,493
Last Updated: Fri 30 Aug 2024 09:59:36 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.45
0.02
5.40%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-09 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-03-05 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 213.953 M | 205.242 M | 240.754 M | 209.952 M | 222.623 M | 187.217 M | 177.769 M | 137.212 M | |
| Current Assets | 161.735 M | 153.427 M | 182.878 M | 154.765 M | 122.376 M | 90.820 M | 87.435 M | 51.853 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.791 M | 6.891 M | 7.014 M | 6.880 M | 5.406 M | 5.630 M | 5.862 M | 4.303 M | |
| Short Term Investments | 7.791 M | 6.891 M | 7.014 M | 6.880 M | 5.406 M | 5.630 M | 5.862 M | 4.303 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 144.633 M | 139.809 M | 171.887 M | 145.808 M | 114.533 M | 83.948 M | 79.274 M | 46.303 M | |
| Total Non-current Assets | 52.218 M | 51.815 M | 57.876 M | 55.187 M | 100.247 M | 96.397 M | 90.334 M | 85.359 M | |
| Property Plant Equipment | 22.712 M | 21.672 M | 21.335 M | 20.365 M | 20.443 M | 18.952 M | 17.281 M | 14.088 M | |
| Other Assets | 24.216 M | 24.853 M | 27.220 M | 29.532 M | 74.514 M | 72.155 M | 67.763 M | 65.981 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 213.953 M | 205.242 M | 240.754 M | 209.952 M | 222.623 M | 187.217 M | 177.769 M | 137.212 M | |
| Total liabilities | 50.575 M | 68.395 M | 69.973 M | 69.074 M | 113.056 M | 113.235 M | 125.919 M | 123.248 M | |
| Total current liabilities | 32.386 M | 32.313 M | 34.801 M | 24.672 M | 22.111 M | 23.383 M | 27.339 M | 25.870 M | |
| Accounts Payable | 2.381 M | 2.885 M | 8.694 M | 5.975 M | 4.925 M | 4.265 M | 3.819 M | 7.248 M | |
| Other liabilities | 389.000 K | 49.000 K | 150.000 K | 251.000 K | 398.000 K | 554.000 K | 709.000 K | 907.000 K | |
| Current long term debt | 7.174 M | 6.325 M | 5.294 M | 4.628 M | 4.838 M | 6.003 M | 6.904 M | 6.811 M | |
| Long term debt | 17.800 M | 36.033 M | 35.022 M | 44.151 M | 90.547 M | 89.298 M | 97.871 M | 96.471 M | |
| Other liabilities | 389.000 K | 49.000 K | 150.000 K | 251.000 K | 398.000 K | 554.000 K | 709.000 K | 907.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 163.378 M | 136.847 M | 170.781 M | 140.878 M | 109.567 M | 73.982 M | 51.850 M | 13.964 M | |
| Common stock | 86.449 M | 86.597 M | 104.350 M | 114.423 M | 114.930 M | 115.343 M | 117.415 M | 118.391 M | |
| Retained earnings | -459.815 M | -489.781 M | -521.071 M | -555.053 M | -590.309 M | -628.743 M | -659.561 M | -699.946 M |